Perception of generic prescription drugs and utilization of generic drug discount programs

Ethnicity and Disease

Volumn 22, Issue 4, 2012, Pages 479-485

  Omojasola, Anthony ^a   Hernandez, Mike ^a   Sansgiry, Sujit ^b   Jones, Lovell ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Generic prescription drugs; Health care access; Health care cost; Prescription drug cost

Indexed keywords

GENERIC DRUG;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DRUG UTILIZATION; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CENTER; HEALTH INSURANCE; HUMAN; MALE; PATIENT ASSESSMENT; PERCEPTION; PRESCRIPTION; UNITED STATES;

ADOLESCENT; ADULT; AGED; ATTITUDE; COST SAVINGS; CROSS-SECTIONAL STUDIES; DRUGS, GENERIC; FEMALE; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; LOGISTIC MODELS; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; TEXAS; YOUNG ADULT;

EID: 84869050296     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rizzo JA, Zeckhauser R. Generic script share and the price of brand-name drugs: the role of consumer choice. Int J Health Care Fi. 2009;9(3):291-316.
2. Shrank WH, Liberman JN, Fischer MA, Girdish C, Brennan TA, Choudhry NK. Physician perceptions about generic drugs. Ann Pharmacother. 2011;45(1):31-38.
3. Kesselheim AS, Misono AS, Lee JL, et al. Clinical equivalence of generic and brandname drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21):2514-2526.
4. Shrank WH, Choudhry NK, Fischer MA, et al. The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med. 2010;153(10):633-640.
5. Gellad WF, Choudhry NK, Friedberg MW, Brookhart MA, Haas JS, Shrank WH. Variation in drug prices at pharmacies: are prices higher in poorer areas? Health Serv Res. 2009;44(2 Pt 1):606-617.
6. Piette JD, Heisler M, Horne R, Caleb Alexander G. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures. Soc Sci Med. 2006;62(4):846-857. (Pubitemid 43087360)
7. Iosifescu A, Halm EA, McGinn T, Siu AL, Federman AD. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns. 2008;73(2): 377-383.
8. Felland LE, Taylor EF, Gerland AM. The community safety net and prescription drug access for low-income, uninsured people. Issue Brief Cent Stud Health Syst Change. 2006; 105:1-4.
9. Shrank WH, Cox ER, Fischer MA, Mehta J, Choudhry NK. Patients' perceptions of generic medications. Health Aff (Millwood). 2009;28(2):546-556.
10. Wilson IB, Schoen C, Neuman P, et al. Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors. J Gen Intern Med. 2007;22(1):6-12. (Pubitemid 47308785)
11. Taira DA, Iwane KA, Chung RS. Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage. Am J Manag Care. 2003;9(4): 305-312. (Pubitemid 36526701)
12. Ranji UR, Wyn R, Salganicoff A, Yu H. Role of health insurance coverage in women's access to prescription medicines. Womens Health Iss. 2007;17(6):360-366. (Pubitemid 350138595)
13. Tseng CW, Dudley RA, Brook RH, et al. Elderly patients' preferences and experiences with providers in managing their drug costs. J Am Geriatr Soc. 2007;55(12):1974-1980. (Pubitemid 350230953)
14. Shrank WH, Cadarette SM, Cox E, et al. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care. 2009;47(3): 319-325.
15. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med. 2005;142(11):891-897.
16. Fischer MA, Avorn J. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit. Pharmacoepidemiol Dr S. 2004;13(4): 207-214. (Pubitemid 38514834)
17. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Generic substitution of antihypertensive drugs: does it affect adherence? Ann Pharmacother. 2006;40(1):15-20. (Pubitemid 43221468)
18. Babar ZU, Stewart J, Reddy S, et al. An evaluation of consumers' knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharm World Sci. 2010;32(4): 440-448.
19. Catlin A, Cowan C, Hartman M, Heffler S. National health spending in 2006: a year of change for prescription drugs. Health Aff (Millwood). 2008;27(1):14-29. (Pubitemid 351198585)
20. Patel H, Dwibedi N, Omojasola A, Sansgiry S. Impact of Generic Drug Discount Programs on Managed Care Organizations. Am J Pharm Benefits. 2011;3(1):45-53.
21. Sansgiry S, Dwibedi N. Assessment of Generic Drug Discount Programs Offered by Large Chain Pharmacies in the United States. J Generic Med. 2009;6:363-368.
22. Zhang Y, Zhou L, Gellad WF. Potential savings from greater use of $4 generic drugs. Arch Intern Med. 2011;171(5):468-469.
23. Alexander GC, Casalino LP, Meltzer DO. Physician strategies to reduce patients' out-ofpocket prescription costs. Arch Intern Med. 2005;165(6):633-636. (Pubitemid 40393144)
24. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164(16):1749-1755. (Pubitemid 39215643)
25. Shrank WH, Asch SM, Joseph GJ, et al. Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs. Ann Pharmacother. 2006;40(9):1534-1540. (Pubitemid 44330197)
26. Shrank WH, Joseph GJ, Choudhry NK, et al. Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most? Am J Manag Care. 2006;12(9):545-551. (Pubitemid 44412035)
27. Hassali MA, Shafie AA, Jamshed S, Ibrahim MI, Awaisu A. Consumers' views on generic medicines: a reviewof the literature. Int J Pharm Pract. 2009;17(2):79-88.
28. Morris KJ. Strategies for acquiring affordable medications for seniors. Nurs Clin North Am. 2005;40(1):51-62, vi. (Pubitemid 40331948)
29. Ascione FJ, Kirking DM, Gaither CA, Welage LS. Historical overview of generic medication policy. J Am Pharm Assoc (Wash). 2001;41(4):567-577.
30. Gaither CA, Kirking DM, Ascione FJ, Welage LS. Consumers' views on generic medications. J Am Pharm Assoc. 2001;41(5):729-736.
31. Federman AD, Halm EA, Siu AL. Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care. Med Care. 2007;45(2):109-115.
32. Salant P, Dillman D. How to Conduct Your Own Survey. New York: John Wiley&Sons, Inc; 1994.
33. Rosner B. Fundamentals of Biostatistics. Fifth ed. Pacific Grove: Duxbury; 2000.
34. George D, Mallery P. SPSS for Windows Step by Step: A Simple Study Guide and Reference, 17.0 Update. 10th ed. Boston: Allyn & Bacon; 2009.
35. Hatcher L. A Step-by-Step Approach to using SAS for Factor Analysis and Structural Equation Modeling. Cary: SAS Publishing; 1994.
36. Figueiras MJ, Marcelino D, Cortes MA. People's views on the level of agreement of generic medicines for different illnesses. Pharm World Sci. 2008;30(5):590-594.
37. Piette JD, Heisler M, Harand A, Juip M. Beliefs about prescription medications among patients with diabetes: variation across racial groups and influences on cost-related medication underuse. J Health Care Poor U. 2010; 21(1):349-361.
38. Shrank WH, Stedman M, Ettner SL, et al. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med. 2007; 22(9):1298-1304. (Pubitemid 47247307)